How do I order a thyroid fine‑needle aspiration biopsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Order a Thyroid Fine-Needle Aspiration Biopsy

Thyroid fine-needle aspiration biopsy (FNAB) should be performed by an experienced operator under ultrasound guidance using a 23-27 gauge needle, and must be ordered based on specific EU-TIRADS classification and size criteria rather than for all thyroid nodules. 1

Pre-Biopsy Assessment Requirements

Determine TSH Level First

  • Measure serum TSH before proceeding with FNAB 1
  • If TSH < 0.4 mIU/L: Order thyroid scintigraphy first to identify autonomous (hot) nodules 1
  • If TSH 0.4-1 mIU/L: Order scintigraphy only if FNAB is already indicated based on ultrasound criteria 1
  • If TSH ≥ 1 mIU/L: Proceed directly to ultrasound-based assessment without scintigraphy 1
  • Do not perform FNAB on autonomous nodules when TSH is in the low-normal range (< 1 mU/L) 1

Apply EU-TIRADS Size Criteria

The decision to order FNAB depends on both the EU-TIRADS score and nodule size 1:

For solid nodules:

  • EU-TIRADS 5 nodules ≤ 10mm: Do not order routine FNAB 1
  • EU-TIRADS 5 nodules > 10mm: Order FNAB 1
  • EU-TIRADS 4 nodules: Order FNAB if > 10mm 1
  • EU-TIRADS 3 nodules: Order FNAB only if ≥ 20mm 1

For mixed (cystic-solid) nodules:

  • Measure only the solid tissue portion separately from the fluid component 1
  • Order FNAB based on EU-TIRADS score of the solid portion if it is accessible and > 10mm 1

Multiple Nodules Strategy

  • Order FNAB for 2-3 nodules maximum, prioritizing those most likely to be cancerous based on EU-TIRADS score and size 1
  • Assess each nodule individually according to its own size and EU-TIRADS classification 1

Ordering the Procedure

Technical Specifications to Include

When ordering the FNAB, specify 1:

  • Ultrasound-guided procedure (not palpation-guided) 1
  • 23-27 gauge needle 1
  • Request experienced operator when possible 1
  • Aspiration technique vs. non-aspiration depends on nodule characteristics (operator will determine) 1

Anticoagulation Management

  • Assess risk/benefit ratio of discontinuing anticoagulation on an individual basis 1
  • This requires case-by-case clinical judgment rather than routine discontinuation 1

Required Clinical Information

Include a requisition form with the following details 1:

  • Complete ultrasound characteristics of the nodule (size, EU-TIRADS score, echogenicity, calcifications, borders, vascularity)
  • Clinical context (TSH level, symptoms, family history, radiation exposure)
  • Whether this is an initial biopsy or repeat procedure 1

Special Considerations

When Calcitonin Measurement is Needed

  • Measure calcitonin before any thyroid surgery or thermal ablation 1
  • Normal calcitonin does not need to be repeated unless genetic predisposition to medullary thyroid cancer exists 1

Hypermetabolic Nodules on PET Scan

If incidental 18F-FDG uptake is present 1:

  • Order FNAB for all hypermetabolic nodules > 1cm classified as EU-TIRADS 4 or 5
  • Order FNAB for hypermetabolic EU-TIRADS 3 nodules ≥ 2cm

After Non-Diagnostic Results

  • If FNAB yields non-diagnostic results twice, order microbiopsy (core needle biopsy) for solid nodules 1

What NOT to Order

  • Do not order CT or MRI for routine initial thyroid nodule assessment 1
  • CT/MRI reserved only for: substernal extension assessment, tracheal/esophageal compression evaluation, preoperative vascular mapping, or lymph node mapping 1
  • Do not order FNAB for nodules that don't meet size/EU-TIRADS criteria above 1

Common Pitfalls to Avoid

  • Ordering FNAB on small (≤10mm) EU-TIRADS 5 nodules—these should be monitored, not biopsied 1
  • Failing to check TSH first and potentially biopsying autonomous nodules unnecessarily 1
  • Ordering biopsies on multiple nodules without prioritizing by malignancy risk 1
  • Not providing adequate clinical information to the cytopathologist, which reduces diagnostic accuracy 1

Related Questions

What do low‑attenuation lesions in the proximal pancreatic tail measuring 2.9 × 1.3 cm with associated atrophy of the distal pancreatic tail and dilatation of the pancreatic duct, together with a 1.7 cm low‑attenuation lesion in the right hepatic lobe on contrast‑enhanced abdominal CT indicate, and what is the likely prognosis?
Why does an ileostomy result in high output?
If a patient's blood pressure falls from 118/68 mm Hg to 104/58 mm Hg, should I change the antihypertensive medication?
What could cause a diastolic blood pressure of 52 mm Hg in a patient with a systolic pressure of 118 mm Hg?
What are the five components of the Babinski (extensor plantar) response?
What are the indications, dosing regimen, administration instructions, contraindications, side effects, and alternative therapies for rebamipide in adults with gastritis, gastric ulcer, or NSAID‑induced gastric injury?
What is the appropriate dosing and administration of psyllium husk for an adult with diverticulosis?
What does a serum alkaline phosphatase (ALP) level of 225 U/L indicate and how should it be evaluated in an otherwise healthy adult?
What is the appropriate dosing regimen of anidulafungin for a patient on venovenous extracorporeal membrane oxygenation (VV ECMO)?
What are the indications, dosing, monitoring, contraindications, drug interactions, and alternative therapies for verapamil?
What are the possible causes and recommended evaluation for dyspareunia with heavy post‑coital bleeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.